×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
OLMA – olema pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OLMA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/11
08:21 am
olma
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
High
Report
Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
12/10
07:07 am
olma
Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination with Ribociclib at the San Antonio Breast Cancer Symposium [Yahoo! Finance]
Low
Report
Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination with Ribociclib at the San Antonio Breast Cancer Symposium [Yahoo! Finance]
12/10
07:00 am
olma
Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination with Ribociclib at the San Antonio Breast Cancer Symposium
Low
Report
Olema Oncology Presents Updated Clinical Results for Palazestrant in Combination with Ribociclib at the San Antonio Breast Cancer Symposium
12/9
07:00 am
olma
Olema Oncology Announces FDA Clearance of Investigational New Drug Application for OP-3136, a Potent KAT6 Inhibitor
High
Report
Olema Oncology Announces FDA Clearance of Investigational New Drug Application for OP-3136, a Potent KAT6 Inhibitor
12/3
04:30 pm
olma
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/2
07:00 am
olma
Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer as well as $250 Million Equity Private Placement
Low
Report
Olema Oncology Announces New Clinical Trial Collaboration and Supply Agreement with Novartis in Frontline Metastatic Breast Cancer as well as $250 Million Equity Private Placement
11/25
05:42 pm
olma
Olema Oncology to Present New Data Combining Palazestrant with Ribociclib at the San Antonio Breast Cancer Symposium [Yahoo! Finance]
Medium
Report
Olema Oncology to Present New Data Combining Palazestrant with Ribociclib at the San Antonio Breast Cancer Symposium [Yahoo! Finance]
11/25
05:30 pm
olma
Olema Oncology to Present New Data Combining Palazestrant with Ribociclib at the San Antonio Breast Cancer Symposium
Medium
Report
Olema Oncology to Present New Data Combining Palazestrant with Ribociclib at the San Antonio Breast Cancer Symposium
Date
Time
Symbol
Headline
Impact
12/18
06:52 pm
olma
Form 4/A Olema Pharmaceuticals, For: Dec 13 Filed by: Graham G. Walmsley
Low
Report
Form 4/A Olema Pharmaceuticals, For: Dec 13 Filed by: Graham G. Walmsley
12/17
07:52 pm
olma
Form 4 Olema Pharmaceuticals, For: Dec 13 Filed by: Graham G. Walmsley
Medium
Report
Form 4 Olema Pharmaceuticals, For: Dec 13 Filed by: Graham G. Walmsley
12/17
07:30 pm
olma
Form 4 Olema Pharmaceuticals, For: Dec 16 Filed by: Zojwalla Naseem
Medium
Report
Form 4 Olema Pharmaceuticals, For: Dec 16 Filed by: Zojwalla Naseem
12/13
04:37 pm
olma
Form 144 Olema Pharmaceuticals, Filed by: Logos Opportunities Fund I LP
Medium
Report
Form 144 Olema Pharmaceuticals, Filed by: Logos Opportunities Fund I LP
12/11
07:57 pm
olma
Form 4 Olema Pharmaceuticals, For: Dec 09 Filed by: Harmon Cyrus
High
Report
Form 4 Olema Pharmaceuticals, For: Dec 09 Filed by: Harmon Cyrus
12/11
07:56 pm
olma
Form 4 Olema Pharmaceuticals, For: Dec 09 Filed by: Myles David C.
High
Report
Form 4 Olema Pharmaceuticals, For: Dec 09 Filed by: Myles David C.
12/11
07:55 pm
olma
Form 4 Olema Pharmaceuticals, For: Dec 09 Filed by: Zojwalla Naseem
High
Report
Form 4 Olema Pharmaceuticals, For: Dec 09 Filed by: Zojwalla Naseem
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: